Cargando…
HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL
BACKGROUND: The role of pro-inflammatory lipids in systemic immune activation in HIV infection remains largely unknown. We hypothesized that HIV-1-infected persons on antiretroviral therapy would have pro-inflammatory high density lipoprotein (HDL), and that an apoA-1 mimetic peptide might reverse t...
Autores principales: | Kelesidis, Theodoros, Yang, Otto O, Currier, Judith S, Navab, Kaveh, Fogelman, Alan M, Navab, Mohamad |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049748/ https://www.ncbi.nlm.nih.gov/pubmed/21345230 http://dx.doi.org/10.1186/1476-511X-10-35 |
Ejemplares similares
-
Effects of lipid-probe interactions in biochemical fluorometric methods that assess HDL redox activity
por: Kelesidis, Theodoros, et al.
Publicado: (2012) -
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults
por: Kelesidis, Theodoros, et al.
Publicado: (2013) -
HDL as a Biomarker, Potential Therapeutic Target, and Therapy
por: Navab, Mohamad, et al.
Publicado: (2009) -
1609 Plasma markers of immune activation likely reflect related but distinct processes of cellular immune activation in HIV-infected persons before and after suppression of viremia by antiretroviral therapy: ACTG 5260
por: Kelesidis, Theodoros, et al.
Publicado: (2014) -
A High Throughput Biochemical Fluorometric Method for Measuring Lipid Peroxidation in HDL
por: Kelesidis, Theodoros, et al.
Publicado: (2014)